EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41534530.
- Also identified by DOI 10.1016/j.cell.2025.12.046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epstein-Barr virus (EBV) is involved in causing and probably also in perpetuating multiple sclerosis (MS). Among several mechanisms of how EBV may contribute are transcriptome alterations, including changes of antigen processing and preferential presentation of both viral and self-antigens. Here, we report that EBV reprograms the transcriptome and immunopeptidome presented on the MS-associated human leukocyte antigen (HLA)-DR15 molecules of infected B cells. Identical myelin basic protein (MBP) peptides were found to be presented on both EBV-infected B cells and MS brain tissue but not primary B cells and thymic tissue. Peripheral memory and cerebrospinal fluid (CSF)-derived CD4<sup>+</sup> T cells of HLA-DR15<sup>+</sup> MS patients responded to MBP peptides, MBP<sub>(78-90)</sub> and/or MBP<sub>(83-90)</sub>, and T cell clones raised with these peptides recognized all MBP peptides ending at amino acid MBP<sub>90</sub> in MS brain tissue. Our study provides a new mechanistic link for how the environmental and genetic risk factors, EBV infection and HLA-DR15 haplotype, may contribute jointly to MS.
Medical subject headings
- Multiple Sclerosis
- Epstein-Barr Virus Infections
- Myelin Basic Protein
- HLA-DR Serological Subtypes
- Antigen Presentation